共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
由严重急性呼吸系统综合征冠状病毒2型(severe acute respiratory syndrome coronavirus-2,SARS-CoV-2)引起的疾病被命名为新型冠状病毒肺炎(coronavirus disease 2019,COVID-19),是一种具有强传染性、高易感性、长潜伏期的传染病。病毒刺突蛋白受体结合结构域(receptor binding domain,RBD)和细胞血管紧张素转换酶2(angiotensin-converting enzyme 2,ACE2)之间的相互作用使得SARS-CoV-2顺利进入细胞。本文对SARS-CoV-2与ACE2的相关作用机制进行了简单概述,对目前针对SARS-CoV-2中和单克隆抗体、纳米抗体的最新研究进展进行了总结,探讨了新冠肺炎的发展过程和抗体药物的研究方向,以期为包括新冠肺炎在内的新发、突发传染病中和抗体药物的研发提供参考。 相似文献
3.
Markus Hoffmann Prerna Arora Rüdiger Groß Alina Seidel Bojan F. Hörnich Alexander S. Hahn Nadine Krüger Luise Graichen Heike Hofmann-Winkler Amy Kempf Martin S. Winkler Sebastian Schulz Hans-Martin Jäck Bernd Jahrsdörfer Hubert Schrezenmeier Martin Müller Alexander Kleger Jan Münch Stefan Pöhlmann 《Cell》2021,184(9):2384-2393.e12
4.
Gabriele Cerutti Yicheng Guo Tongqing Zhou Jason Gorman Myungjin Lee Micah Rapp Eswar R. Reddem Jian Yu Fabiana Bahna Jude Bimela Yaoxing Huang Phinikoula S. Katsamba Lihong Liu Manoj S. Nair Reda Rawi Adam S. Olia Pengfei Wang Baoshan Zhang Lawrence Shapiro 《Cell host & microbe》2021,29(5):819-833.e7
5.
6.
新型冠状病毒的全球大流行,给人类的生命健康和社会秩序带来了巨大的危害。疫苗、小分子药物及各类抗体药物的研发在遏制新型冠状病毒感染传播、降低重症率和死亡风险上发挥了积极的作用。然而,由于新冠病毒庞大的感染基数及自身易突变的特征,当前已经演化出多种能逃逸疫苗及中和抗体的变异株,显著削弱了抗体的保护效果。研发新型冠状病毒广谱甚至泛β冠状病毒广谱的中和抗体对于未来新冠变异株及其他高致病性β冠状病毒的防治具有重要意义。本文从新型冠状病毒中和抗体的筛选制备策略、作用机制、中和效果及广谱性等方面进行了系统综述,并对当前面临的挑战和未来的发展方向进行了讨论和展望,以期为后续相关研究提供参考。 相似文献
7.
8.
Nicola Cotugno Alessandra Ruggiero Francesco Bonfante Maria Raffaella Petrara Sonia Zicari Giuseppe Rubens Pascucci Paola Zangari Maria Antonietta De Ioris Veronica Santilli E.C. Manno Donato Amodio Alessio Bortolami Matteo Pagliari Carlo Concato Giulia Linardos Andrea Campana Daniele Donà Carlo Giaquinto 《Cell reports》2021,34(11):108852
9.
10.
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. With the continuous evolution of the viral genome, SARS-CoV-2 has evolved many variants. B.1.617.2, also called Delta, is one of the most concerned variants. The Delta variant was first reported in India at the end of 2020 but has spread globally, by now, to 135 countries and is not stand still. Delta shared some mutations with other variants, and owned its special mutations on spike proteins, which may be responsible for its strong transmission and increasing virulence. Under these circumstances, a systematic summary of Delta is necessary. This review will focus on the Delta variant. We will describe all the characteristics of Delta (including biological features and clinical characteristics), analyze potential reasons for its strong transmission, and provide potential protective ways for combating Delta. 相似文献
11.
It has been more than a year since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged. Many studies have provided insights into the various aspects of the immune response in coronavirus disease 2019 (COVID-19). Especially for antibody treatment and vaccine development, humoral immunity to SARS-CoV-2 has been studied extensively, though there is still much that is unknown and controversial. Here, we introduce key discoveries on the humoral immune responses in COVID-19, including the immune dynamics of antibody responses and correlations with disease severity, neutralizing antibodies and their cross-reactivity, how long the antibody and memory B-cell responses last, aberrant autoreactive antibodies generated in COVID-19 patients, and the efficacy of currently available therapeutic antibodies and vaccines against circulating SARS-CoV-2 variants, and highlight gaps in the current knowledge. 相似文献
12.
Daniel Asarnow Bei Wang Wen-Hsin Lee Yuanyu Hu Ching-Wen Huang Bryan Faust Patricia Miang Lon Ng Eve Zi Xian Ngoh Markus Bohn David Bulkley Andrés Pizzorno Beatrice Ary Hwee Ching Tan Chia Yin Lee Rabiatul Adawiyah Minhat Olivier Terrier Mun Kuen Soh Frannie Jiuyi Teo Cheng-I Wang 《Cell》2021,184(12):3192-3204.e16
13.
14.
《Cell》2021,184(16):4203-4219.e32
15.
16.
Dongyan Zhou Jasper Fuk-Woo Chan Biao Zhou Runhong Zhou Shuang Li Sisi Shan Li Liu Anna Jinxia Zhang Serena J. Chen Chris Chung-Sing Chan Haoran Xu Vincent Kwok-Man Poon Shuofeng Yuan Cun Li Kenn Ka-Heng Chik Chris Chun-Yiu Chan Jianli Cao Chun-Yin Chan Zhiwei Chen 《Cell host & microbe》2021,29(4):551-563.e5
17.
18.
19.
Richard Copin Alina Baum Elzbieta Wloga Kristen E. Pascal Stephanie Giordano Benjamin O. Fulton Anbo Zhou Nicole Negron Kathryn Lanza Newton Chan Angel Coppola Joyce Chiu Min Ni Yi Wei Gurinder S. Atwal Annabel Romero Hernandez Kei Saotome Yi Zhou Christos A. Kyratsous 《Cell》2021,184(15):3949-3961.e11
20.
Xinghai Zhang Shaohong Chen Zengguo Cao Yanfeng Yao Junping Yu Junhui Zhou Ge Gao Ping He Zhuo Dong Jie Zhong Jing Luo Hongping Wei Huajun Zhang 《中国病毒学》2022,37(6):796-803
During the two-year pandemic of coronavirus disease 2019 (COVID-19), its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been evolving. SARS-CoV-2 Delta, a variant of concern, has become the dominant circulating strain worldwide within just a few months. Here, we performed a comprehensive analysis of a new B.1.617.2 Delta strain (Delta630) compared with the early WIV04 strain (WIV04) in vitro and in vivo, in terms of replication, infectivity, pathogenicity, and transmission in hamsters. When inoculated intranasally, Delta630 led to more pronounced weight loss and more severe disease in hamsters. Moreover, 40% mortality occurred about one week after infection with 104 PFU of Delta630, whereas no deaths occurred even after infection with 105 PFU of WIV04 or other strains belonging to the Delta variant. Moreover, Delta630 outgrew over WIV04 in the competitive aerosol transmission experiment. Taken together, the Delta630 strain showed increased replication ability, pathogenicity, and transmissibility over WIV04 in hamsters. To our knowledge, this is the first SARS-CoV-2 strain that causes death in a hamster model, which could be an asset for the efficacy evaluation of vaccines and antivirals against infections of SARS-CoV-2 Delta strains. The underlying molecular mechanisms of increased virulence and transmission await further analysis. 相似文献